DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,487 | -0.5% | 727 | -3.7% | 0.02% | 0.0% |
| Q2 2023 | $181,395 | +42.4% | 755 | +49.5% | 0.02% | +36.4% |
| Q1 2023 | $127,352 | +100973.0% | 505 | +7.0% | 0.01% | -8.3% |
| Q4 2022 | $126 | -99.9% | 472 | 0.0% | 0.01% | -7.7% |
| Q3 2022 | $122,000 | -10.9% | 472 | -12.4% | 0.01% | 0.0% |
| Q2 2022 | $137,000 | -18.5% | 539 | -5.8% | 0.01% | -13.3% |
| Q1 2022 | $168,000 | -13.4% | 572 | -2.9% | 0.02% | -16.7% |
| Q4 2021 | $194,000 | +14.8% | 589 | +5.9% | 0.02% | +5.9% |
| Q3 2021 | $169,000 | +14.2% | 556 | +0.9% | 0.02% | +13.3% |
| Q2 2021 | $148,000 | +31.0% | 551 | +10.2% | 0.02% | +25.0% |
| Q1 2021 | $113,000 | +68.7% | 500 | +67.2% | 0.01% | +50.0% |
| Q4 2020 | $67,000 | +8.1% | 299 | +3.1% | 0.01% | +14.3% |
| Q3 2020 | $62,000 | -82.7% | 290 | -85.7% | 0.01% | -83.3% |
| Q2 2020 | $358,000 | +31.1% | 2,024 | +2.6% | 0.04% | +16.7% |
| Q1 2020 | $273,000 | -9.6% | 1,972 | +0.1% | 0.04% | -2.7% |
| Q4 2019 | $302,000 | +9.4% | 1,970 | +3.1% | 0.04% | +2.8% |
| Q3 2019 | $276,000 | -17.1% | 1,910 | -17.4% | 0.04% | -18.2% |
| Q2 2019 | $333,000 | +1.8% | 2,312 | -8.4% | 0.04% | +2.3% |
| Q1 2019 | $327,000 | +20.7% | 2,525 | 0.0% | 0.04% | +7.5% |
| Q4 2018 | $271,000 | +10.2% | 2,525 | +6.5% | 0.04% | -7.0% |
| Q3 2018 | $246,000 | +30.2% | 2,372 | +23.9% | 0.04% | +53.6% |
| Q2 2018 | $189,000 | -2.6% | 1,915 | 0.0% | 0.03% | -3.4% |
| Q1 2018 | $194,000 | -8.1% | 1,915 | -9.5% | 0.03% | -6.5% |
| Q4 2017 | $211,000 | +24.1% | 2,115 | +8.0% | 0.03% | +10.7% |
| Q3 2017 | $170,000 | -6.1% | 1,958 | -7.4% | 0.03% | -12.5% |
| Q2 2017 | $181,000 | +11.0% | 2,115 | +11.3% | 0.03% | +3.2% |
| Q1 2017 | $163,000 | +11.6% | 1,900 | +3.3% | 0.03% | +6.9% |
| Q4 2016 | $146,000 | – | 1,840 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |